Neutra Corp. (NTRR) Strengthens its Health and Nut
Post# of 70
(Total Views: 289)
Posted On: 09/12/2019 5:43:00 PM
Neutra Corp. (NTRR) Strengthens its Health and Nutritional Product Line with Strategic Purchase of Emerging CBD Retail Brand
- The company’s strategic acquisition of Vivis Corp. is expected to help meet demand for high quality, potent, hemp-extracted CBD consumer products
- U.S. sales of cannabis- and hemp-derived CBD products are expected to surge to $20 billion by 2024, with a CAGR of 49 percent
- NTRR’s acquisition of hemp cultivator J3 Holdings is expected to enable Neutra Corp. to grow its own hemp supply, ensuring the quality and potency of its CBD products
Neutra Corp. (OTCQB: NTRR), an early stage research and development company focusing on modern healthy living solutions, is concentrating on developing into a vertically integrated company able to cultivate, manufacture and distribute hemp-based cannabidiol (CBD) products. Recently announced tactical acquisitions make the company’s intentions clear, as Neutra Corp. CEO Sydney Jim detailed in a recent interview (http://nnw.fm/gZ3jU).
“In 2019 we’re really looking at trying to figure out how to participate in the hemp-based CBD market. Our overall goal is to become a vertically integrated company from cultivation to manufacturing to formulation of products and then to distribution and retail sales,” Jim said in the interview. “Most of our focus, obviously, is on our quality and our potency of products, because there is a vast difference between a very cheap product and a quality product.”
The U.S. cannabis- and hemp-derived CBD market is expected to reach $20 billion by 2024, driven at a compound annual growth rate of 49 percent, according to leading cannabis researchers BDS Analytics and Arcview Market Research (http://nnw.fm/9e3wS). The report predicts that the majority of CBD product sales will soon occur in general retail stores, rather than in cannabis dispensaries.
Neutra Corp.’s previously announced acquisition of Vivis Corp., an emerging retail brand of hemp-based health and nutritional products, is a natural fit for the company. All Vivis CBD products are third-party tested and certified, assuring the consumer that its hemp-derived CBD products are contaminant-free and of a consistently high purity (http://nnw.fm/yMs0O).
Neutra’s acquisition of J3 Holdings, which currently owns land, a warehouse and licensing to cultivate hemp and refine it into useable forms, is expected to enable the company to grow its own hemp supply, giving it control over the quality of its end products, according to a news release (http://nnw.fm/3d9ZT).
“This is a big acquisition and a great demonstration of the continued evolution of our company,” Jim stated in the news release. “This shows we’re moving forward with our plans to become a serious player in the ever-growing CBD market. CBD products are rapidly gaining mainstream acceptance.”
The U.S. Drug Enforcement Administration (DEA) recently updated its guidance to remind law enforcement that hemp is no longer a controlled substance and that certain forms of cannabis no longer require DEA registration to grow, manufacture or research (http://nnw.fm/S7qfY). The clarification, made August 26, 2019, is a much needed and timely statement in light of CBD’s growing popularity with the general population.
For more information, visit the company’s website at www.NeutraInc.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- The company’s strategic acquisition of Vivis Corp. is expected to help meet demand for high quality, potent, hemp-extracted CBD consumer products
- U.S. sales of cannabis- and hemp-derived CBD products are expected to surge to $20 billion by 2024, with a CAGR of 49 percent
- NTRR’s acquisition of hemp cultivator J3 Holdings is expected to enable Neutra Corp. to grow its own hemp supply, ensuring the quality and potency of its CBD products
Neutra Corp. (OTCQB: NTRR), an early stage research and development company focusing on modern healthy living solutions, is concentrating on developing into a vertically integrated company able to cultivate, manufacture and distribute hemp-based cannabidiol (CBD) products. Recently announced tactical acquisitions make the company’s intentions clear, as Neutra Corp. CEO Sydney Jim detailed in a recent interview (http://nnw.fm/gZ3jU).
“In 2019 we’re really looking at trying to figure out how to participate in the hemp-based CBD market. Our overall goal is to become a vertically integrated company from cultivation to manufacturing to formulation of products and then to distribution and retail sales,” Jim said in the interview. “Most of our focus, obviously, is on our quality and our potency of products, because there is a vast difference between a very cheap product and a quality product.”
The U.S. cannabis- and hemp-derived CBD market is expected to reach $20 billion by 2024, driven at a compound annual growth rate of 49 percent, according to leading cannabis researchers BDS Analytics and Arcview Market Research (http://nnw.fm/9e3wS). The report predicts that the majority of CBD product sales will soon occur in general retail stores, rather than in cannabis dispensaries.
Neutra Corp.’s previously announced acquisition of Vivis Corp., an emerging retail brand of hemp-based health and nutritional products, is a natural fit for the company. All Vivis CBD products are third-party tested and certified, assuring the consumer that its hemp-derived CBD products are contaminant-free and of a consistently high purity (http://nnw.fm/yMs0O).
Neutra’s acquisition of J3 Holdings, which currently owns land, a warehouse and licensing to cultivate hemp and refine it into useable forms, is expected to enable the company to grow its own hemp supply, giving it control over the quality of its end products, according to a news release (http://nnw.fm/3d9ZT).
“This is a big acquisition and a great demonstration of the continued evolution of our company,” Jim stated in the news release. “This shows we’re moving forward with our plans to become a serious player in the ever-growing CBD market. CBD products are rapidly gaining mainstream acceptance.”
The U.S. Drug Enforcement Administration (DEA) recently updated its guidance to remind law enforcement that hemp is no longer a controlled substance and that certain forms of cannabis no longer require DEA registration to grow, manufacture or research (http://nnw.fm/S7qfY). The clarification, made August 26, 2019, is a much needed and timely statement in light of CBD’s growing popularity with the general population.
For more information, visit the company’s website at www.NeutraInc.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Neutra Corp (NTRR) Stock Research Links
Scroll down for more posts ▼